U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
174631174631A Study to Determine Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients During the Period of Time Around Major Orthopedic Surgery.CompletedNo Results AvailableAnemia|Blood Transfusion|Orthopedic ProceduresDrug: epoetin alfahttps://ClinicalTrials.gov/show/NCT00270088
174632174632A Study to Determine the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Not Anemic and Who Will be Undergoing Orthopedic or Heart and Blood Vessel SurgeryCompletedNo Results AvailableBlood Transfusion|Blood Transfusion, Autologous|Orthopedic Procedures|Orthopedic Surgery|Cardiovascular Surgical ProcedureDrug: epoetin alfahttps://ClinicalTrials.gov/show/NCT00270075
174633174633A Study to Evaluate the Safety of Epoetin Alfa and Its Effectiveness in Facilitating the Presurgical Collection of Blood From Anemic Patients for Possible Self-transfusion During and After Scheduled Joint Surgery.CompletedNo Results AvailableAnemiaDrug: epoetin alfahttps://ClinicalTrials.gov/show/NCT00270062
174634174634Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic LeukemiaCompletedNo Results AvailableAnemia|Leukemia, Lymphocytic, Chronic|Leukemia, Lymphocytic|Cancer|Neoplasms|Quality of LifeDrug: epoetin alfahttps://ClinicalTrials.gov/show/NCT00270049
174635174635A Study to Determine the Safety of Epoetin Alfa and Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients After Major Orthopedic Surgery.CompletedNo Results AvailableBlood Transfusion|Orthopedic Procedures|AnemiaDrug: epoetin alfahttps://ClinicalTrials.gov/show/NCT00270036
174636174636A Study to Determine the Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Non-anemic Patients Who Are Undergoing Orthopedic, Heart and Blood Vessel, or Breast Reduction Surgery; Performed in Combination With a ProceduCompletedNo Results AvailableBlood Transfusion|Blood Transfusion, Autologous|Orthopedic Procedures|Orthopedic Surgery|Cardiovascular Surgical Procedures|MammaplastyDrug: epoetin alfahttps://ClinicalTrials.gov/show/NCT00270023
174637174637A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their DiseaseCompletedNo Results AvailableAnemia|Acquired Immunodeficiency SyndromeDrug: epoetin alfahttps://ClinicalTrials.gov/show/NCT00270010
174638174638A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia as a Result of Cancer Treatment With Cisplatin, a Platinum-containing Chemotherapy DrugCompletedNo Results AvailableAnemia|NeoplasmsDrug: epoetin alfahttps://ClinicalTrials.gov/show/NCT00269997
174639174639A Study to Determine the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia Caused by Advanced CancerCompletedNo Results AvailableAnemiaDrug: Epoetin alfahttps://ClinicalTrials.gov/show/NCT00269984
174640174640A Study to Determine an Effective Dose of Epoetin Alfa to Decrease the Number of Units of Blood Required to be Transfused During Hip Replacement Surgery.WithdrawnNo Results AvailableAnemia|Blood Transfusion|Orthopedic SurgeryDrug: epoetin alfahttps://ClinicalTrials.gov/show/NCT00269971
174641174641A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo to Reduce the Need for Blood Transfusions and Reduce the Occurrence of Severe Anemia During the Time Period Surrounding Total Hip Replacement SurgeryCompletedNo Results AvailableAnemiaDrug: epoetin alfahttps://ClinicalTrials.gov/show/NCT00269958
174642174642A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their DiseaseCompletedNo Results AvailableAnemia|Acquired Immunodeficiency SyndromeDrug: epoetin alfahttps://ClinicalTrials.gov/show/NCT00269945
174643174643A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Cefuroxime Axetil in the Treatment of Adults With Persistent Bronchitis Experiencing Rapid Onset of Severe Worsening of Symptoms Caused by BacteriaCompletedNo Results AvailableBronchitis, ChronicDrug: levofloxacinhttps://ClinicalTrials.gov/show/NCT00269932
174644174644An Efficacy and Safety Study of Long-Term Risperidone Microspheres in Participants With SchizophreniaCompletedHas ResultsSchizophrenia|Schizoaffective DisorderDrug: Risperidone Long-Acting Injectable (RLAI)https://ClinicalTrials.gov/show/NCT00269919
174645174645A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Patients With Unstable Angina Not Responding to Standard Medical Therapy Who Are Eligible for Coronary AngioplastyCompletedNo Results AvailableAngina, Unstable|Angioplasty, Transluminal, Percutaneous CoronaryDrug: Abciximab|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00269906
174646174646A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-platelet Therapy, in Patients Undergoing High-risk Coronary AngioplastyCompletedNo Results AvailableAngina, Unstable|Angioplasty, Transluminal, Percutaneous CoronaryDrug: Abciximab|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00269893
174647174647A Study Comparing the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Combination With Two Different Heparin Regimens in Patients Undergoing Percutaneous Coronary Intervention.CompletedNo Results AvailableAngioplasty, Transluminal, Percutaneous CoronaryDrug: Placebo|Drug: Heparin|Drug: Abciximabhttps://ClinicalTrials.gov/show/NCT00269880
174648174648Infliximab Plus Methotrexate for the Treatment of Rheumatoid ArthritisCompletedNo Results AvailableRheumatoid ArthritisDrug: Placebo|Drug: Infliximab 3 mg/kg|Drug: Infliximab 10 mg/kghttps://ClinicalTrials.gov/show/NCT00269867
174649174649An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's DiseaseCompletedNo Results AvailableCrohn DiseaseDrug: Infliximab 5 mg/kg|Drug: Infliximab 10 mg/kg|Drug: Infliximab 20 mg/kg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00269854
174650174650An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Fistulizing Crohn's DiseaseCompletedNo Results AvailableCrohn DiseaseDrug: Infliximab 10 mg/kg|Drug: Infliximab 5 mg/kg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00269841
174651174651A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.TerminatedNo Results AvailableNSCLCDrug: paclitaxel|Drug: paclitaxel poliglumexhttps://ClinicalTrials.gov/show/NCT00269828
174652174652Long-term Safety and Effectiveness of OROS Methylphenidate HCl in Children With Attention Deficit Hyperactivity DisorderCompletedNo Results AvailableAttention Deficit Hyperactivity DisorderDrug: methylphenidate HClhttps://ClinicalTrials.gov/show/NCT00269815
174653174653A Multicenter Study Comparing the Efficacy and Safety of OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity DisorderCompletedNo Results AvailableAttention Deficit Hyperactivity DisorderDrug: OROS methylphenidate HCl|Drug: Ritalin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00269802
174654174654A Comparative Effectiveness Study Evaluating OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl), and Placebo for the Treatment of Attention Deficit Hyperactivity Disorder in ChildrenCompletedNo Results AvailableAttention Deficit Hyperactivity DisorderDrug: Ritalin|Drug: OROS Methylphenidate HCl|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00269789
174655174655An Effectiveness and Safety Study Evaluating OROS Methylphenidate Hydrochloride (HCl), Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity DisorderCompletedNo Results AvailableAttention Deficit Hyperactivity DisorderDrug: Placebo|Drug: OROS (methylphenidate HCl)|Drug: Ritalin (methylphenidate)https://ClinicalTrials.gov/show/NCT00269776
174656174656Clinical Use and Safety of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With CancerCompletedNo Results AvailablePain|CancerDrug: Fentanyl Transdermal Therapeutic System (TTS)https://ClinicalTrials.gov/show/NCT00269763
174657174657A Study Comparing the Efficacy and Safety of OROS® Oxybutynin to That of Ditropan® (Immediate-release Oxybutynin) for the Treatment of Patients With Urge or Mixed Urinary Incontinence.CompletedNo Results AvailableUrge IncontinenceDrug: OROS® oxybutynin or Ditropan®https://ClinicalTrials.gov/show/NCT00269750
174658174658Efficacy of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With CancerCompletedNo Results AvailablePain|CancerDrug: Fentanyl Transdermal Therapeutic System (TTS)https://ClinicalTrials.gov/show/NCT00269737
174659174659A Study to Evaluate the Safety and Efficacy of OROS® Oxybutynin Chloride for the Treatment of Urge Urinary IncontinenceCompletedNo Results AvailableUrinary IncontinenceDrug: OROS® oxybutyninhttps://ClinicalTrials.gov/show/NCT00269724
174660174660Comparison of Vasopressin and Other Pressors in Septic ShockCompletedNo Results AvailableShock, SepticDrug: vasopressinhttps://ClinicalTrials.gov/show/NCT00269685

* Görseller ve İçerik tekif hakkına sahip olabilir